Uncategorised - European Medical Journal

New Fingerstick Test Detects Hepatitis B Within One Hour

New Fingerstick Test Detects Hepatitis B Within 1 Hour

A new point-of-care fingerstick test detects HBV within one hour, a 2026 diagnostic accuracy study has found.

Close-up of a healthcare professional putting on protective medical gloves during an infectious disease clinic examination.

Mpox-HIV Coinfection Tied to Higher Hospitalization

Mpox-HIV coinfection in MSM was linked to more severe symptoms and higher hospitalization, in Hangzhou case series of 104 patients.

3D Printing Reshapes Surgical Training

3D Printing Reshapes Surgical Training

Fused Deposition Modelling 3D printing has become a practical, accessible, and cost-effective tool in surgical settings, a 2026 systematic review has found.

Child sleeping at home, pediatric obstructive sleep apnea and viral infection risk concept

Pediatric Obstructive Sleep Apnea Raises Viral Infection Risk

Pediatric obstructive sleep apnea raised influenza and COVID-19 diagnoses over five years in a U.S. TriNetX large EHR cohort study.

FDA ends ‘two-trial dogma’ in historic shift

The FDA has announced that a single clinical trial will now be the default requirement for the approval of novel medicines.

Transcatheter Falls Short of Surgical Aortic Valve Replacement

Transcatheter aortic valve implantation results in a higher risk of mortality and stroke compared with surgical replacement, a 2026 systematic review has found.

GLP-1 Receptor Agonists Linked to Lower Dementia Risk in CKD

GLP-1 receptor agonists were associated with lower dementia and Alzheimer’s risk in patients with type 2 diabetes and CKD stage 3 or later.

Editor's Pick: Why Point of Care Ultrasound Is More than the Modern Rheumatologist’s Stethoscope

Ultrasound (US) is a very helpful clinical tool in rheumatology due to its low cost, portability, and accessibility for point of…

Few GLP 1 Studies Report Dietary Outcomes

A review of 41 trials finds only two assessed dietary intake with GLP 1 receptor agonists, underscoring a critical gap in nutrition research.

Elenagen Combination Extends Survival in Ovarian Cancer

Phase two data show Elenagen combined with gemcitabine significantly prolongs overall survival in platinum resistant ovarian cancer without added safety concerns.